Exelixis
EXEL
328 hedge funds and large institutions have $4.17B invested in Exelixis in 2019 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 103 increasing their positions, 115 reducing their positions, and 54 closing their positions.
27% more call options, than puts
Call options by funds: $31.4M | Put options by funds: $24.8M
0.71% more ownership
Funds ownership: 78.35% → 79.06% (+0.71%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1% less capital invested
Capital invested by funds: $4.2B → $4.17B (-$29.3M)
2% less first-time investments, than exits
New positions opened: 53 | Existing positions closed: 54
3% less funds holding
Funds holding: 339 → 328 (-11)
10% less repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 115
Top Buyers
Top Sellers
EXEL Hedge Fund Activity: Q4 2019 in Review
328 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q4 2019, worth a combined $4.17B — down 0.7% from $4.2B a quarter earlier.
Sellers outnumbered buyers: 54 funds closed out of EXEL and 53 opened new positions — a net loss of 1 holder — while 115 trimmed existing stakes and 103 added.
The largest buyer was Farallon Capital Management, adding an estimated $97.5M. The largest seller was AQR Capital Management, cutting an estimated $81M.
- 328 institutional investors held Exelixis (EXEL) as of Q4 2019, down from 339 in Q3 2019.
- Funds reported $4.17B of Exelixis stock for Q4 2019, down 0.7% quarter-over-quarter.
- 53 funds opened new Exelixis positions in Q4 2019 and 54 closed out, a net change of -1 holder.
- The largest Exelixis buyer in Q4 2019 was Farallon Capital Management, an estimated $97.5M added.
- The largest Exelixis seller in Q4 2019 was AQR Capital Management, an estimated $81M sold.
Based on aggregated 13F filings for Q4 2019.